These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 9880070)

  • 21. Neuropeptide Y in the central nucleus of the amygdala suppresses dependence-induced increases in alcohol drinking.
    Gilpin NW; Misra K; Koob GF
    Pharmacol Biochem Behav; 2008 Sep; 90(3):475-80. PubMed ID: 18501411
    [TBL] [Abstract][Full Text] [Related]  

  • 22. NPY mediates reward activity of morphine, via NPY Y1 receptors, in the nucleus accumbens shell.
    Desai SJ; Upadhya MA; Subhedar NK; Kokare DM
    Behav Brain Res; 2013 Jun; 247():79-91. PubMed ID: 23511250
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Ghrelin interacts with neuropeptide Y Y1 and opioid receptors to increase food reward.
    Skibicka KP; Shirazi RH; Hansson C; Dickson SL
    Endocrinology; 2012 Mar; 153(3):1194-205. PubMed ID: 22210742
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Neuropeptide Y system in accumbens shell mediates ethanol self-administration in posterior ventral tegmental area.
    Borkar CD; Upadhya MA; Shelkar GP; Subhedar NK; Kokare DM
    Addict Biol; 2016 Jul; 21(4):766-75. PubMed ID: 25929272
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Stimulation of 5-HT(2A/2C) receptors within specific hypothalamic nuclei differentially antagonizes NPY-induced feeding.
    Currie PJ; Coscina DV
    Neuroreport; 1997 Dec; 8(17):3759-62. PubMed ID: 9427365
    [TBL] [Abstract][Full Text] [Related]  

  • 26. WRYamide, a NPY-based tripeptide that antagonizes feeding in rats.
    Chance WT; Tao Z; Sheriff S; Balasubramaniam A
    Brain Res; 1998 Aug; 803(1-2):39-43. PubMed ID: 9729264
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Neuropeptide Y in central control of feeding and interactions with orexin and leptin.
    Niimi M; Sato M; Taminato T
    Endocrine; 2001 Mar; 14(2):269-73. PubMed ID: 11394646
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Neuropeptide Y administration into the amygdala alters high fat food intake.
    Primeaux SD; York DA; Bray GA
    Peptides; 2006 Jul; 27(7):1644-51. PubMed ID: 16426702
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The novel neuropeptide Y Y(1) receptor antagonist J-104870: a potent feeding suppressant with oral bioavailability.
    Kanatani A; Kanno T; Ishihara A; Hata M; Sakuraba A; Tanaka T; Tsuchiya Y; Mase T; Fukuroda T; Fukami T; Ihara M
    Biochem Biophys Res Commun; 1999 Dec; 266(1):88-91. PubMed ID: 10581170
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Increased sensitivity to amphetamine and reward-related stimuli following social isolation in rats: possible disruption of dopamine-dependent mechanisms of the nucleus accumbens.
    Jones GH; Marsden CA; Robbins TW
    Psychopharmacology (Berl); 1990; 102(3):364-72. PubMed ID: 2251333
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Intra-amygdala infusion of the NPY Y1 receptor antagonist BIBP 3226 attenuates operant ethanol self-administration.
    Schroeder JP; Olive F; Koenig H; Hodge CW
    Alcohol Clin Exp Res; 2003 Dec; 27(12):1884-91. PubMed ID: 14691375
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effects of dopamine antagonists and accumbens dopamine depletions on time-constrained progressive-ratio performance.
    Aberman JE; Ward SJ; Salamone JD
    Pharmacol Biochem Behav; 1998 Dec; 61(4):341-8. PubMed ID: 9802826
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Differential effects of neuropeptide Y and the mu-agonist DAMGO on 'palatability' vs. 'energy'.
    Giraudo SQ; Grace MK; Billington CJ; Levine AS
    Brain Res; 1999 Jul; 834(1-2):160-3. PubMed ID: 10407107
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Nucleus accumbens shell and core dopamine responsiveness to sucrose in rats: role of response contingency and discriminative/conditioned cues.
    Bassareo V; Cucca F; Musio P; Lecca D; Frau R; Di Chiara G
    Eur J Neurosci; 2015 Mar; 41(6):802-9. PubMed ID: 25645148
    [TBL] [Abstract][Full Text] [Related]  

  • 35. D1 or D2 antagonism in nucleus accumbens core or dorsomedial shell suppresses lever pressing for food but leads to compensatory increases in chow consumption.
    Nowend KL; Arizzi M; Carlson BB; Salamone JD
    Pharmacol Biochem Behav; 2001; 69(3-4):373-82. PubMed ID: 11509194
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Potentiation of the effects of reward-related stimuli by dopaminergic-dependent mechanisms in the nucleus accumbens.
    Cador M; Taylor JR; Robbins TW
    Psychopharmacology (Berl); 1991; 104(3):377-85. PubMed ID: 1924645
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Neuropeptide Y suppresses prolactin secretion from rat anterior pituitary cells: evidence for interactions with dopamine through inhibitory coupling to calcium entry.
    Wang J; Ciofi P; Crowley WR
    Endocrinology; 1996 Feb; 137(2):587-94. PubMed ID: 8593806
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Neuropeptide Y and behaviour: effects of intrastriatal NPY on circling behaviour of rats.
    Moore E; Merali Z; Beninger RJ
    Pol J Pharmacol Pharm; 1990; 42(6):521-5. PubMed ID: 2103003
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Intracerebroventricular administration of neuropeptide Y affects parameters of dopamine, glutamate and GABA activities in the rat striatum.
    Kerkerian-Le Goff L; Forni C; Samuel D; Bloc A; Dusticier N; Nieoullon A
    Brain Res Bull; 1992 Feb; 28(2):187-93. PubMed ID: 1596740
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Distinct contributions of dopamine receptors in the nucleus accumbens core or shell to established cocaine reinforcement under a second-order schedule.
    Di Ciano P
    Eur Neuropsychopharmacol; 2008 Dec; 18(12):888-96. PubMed ID: 18760571
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.